SwePub
Sök i LIBRIS databas

  Extended search

L773:1741 0541 OR L773:1744 828X
 

Search: L773:1741 0541 OR L773:1744 828X > (2015-2019) > Characterization of...

Characterization of farnesyl diphosphate farnesyl transferase 1 (FDFT1) expression in cancer

Tuzmen, S (author)
Hostetter, G (author)
Watanabe, A (author)
show more...
Ekmekci, C (author)
Carrigan, PE (author)
Shechter, I (author)
Kallioniemi, O (author)
Karolinska Institutet
Miller, LJ (author)
Mousses, S (author)
show less...
 (creator_code:org_t)
Future Medicine Ltd, 2019
2019
English.
In: Personalized medicine. - : Future Medicine Ltd. - 1744-828X .- 1741-0541. ; 16:1, s. 51-65
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Aim: To help characterize the FDFT1 gene and protein expression in cancer. Cholesterol represents an important structural component of lipid rafts. These specializations can be involved in pathways stimulating cell growth, survival and other processes active in cancer. This cellular compartment can be expanded by acquisition of cholesterol from the circulation or by its synthesis in a metabolic pathway regulated by the FDFT1 enzyme. Given the critical role this might play in carcinogenesis and in the behavior of cancers, we have examined the level of this enzyme in various types of human cancer. Our demonstration of elevated levels of FDFT1 mRNA and protein in some tumors relative to surrounding normal tissue identifies this as a possible biomarker for disease development and progression, and as a potential new target for the treatment of cancer.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view